Drugs / Trivalent Oral Polio Vaccine
Trivalent Oral Polio Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01831050 | May 2013 → Apr 2014 | poliomyelitis | Fidec Corporation | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01813604 Comparator | Nov 2012 → Nov 2013 | poliomyelitis | Centers for Disease Control and Prevention | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Trivalent Oral Polio Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01813604 ↗ |
| Known as | tOPV | “trivalent oral polio vaccine (tOPV)” NCT01813604 ↗ |
| Known as | Trivalent Oral Polio Vaccine (tOPV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01831050 ↗ |
| Modality | Vaccine | “trivalent oral polio vaccine” NCT01813604 ↗ |
| Route | Oral | “trivalent oral polio vaccine” NCT01813604 ↗ |